Your browser doesn't support javascript.
loading
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group.
Defina, Marzia; Lazzarotto, Davide; Guolo, Fabio; Minetto, Paola; Fracchiolla, Nicola Stefano; Giglio, Fabio; Forghieri, Fabio; Vitale, Antonella; Chiaretti, Sabina; Papayannidis, Cristina; Piccini, Matteo; Mulè, Antonino; Bocchia, Monica; Leoncin, Matteo; Gurrieri, Carmela; Aprile, Lara; Lunghi, Monia; Bonifacio, Massimiliano; Pasciolla, Crescenza; Cerrano, Marco; Fumagalli, Monica; Foà, Robin; Candoni, Anna.
Afiliación
  • Defina M; Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy. Electronic address: marzia.defina@ao-siena.toscana.it.
  • Lazzarotto D; Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Integrata Friuli Centrale (ASUFC), Udine, Italy.
  • Guolo F; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
  • Minetto P; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
  • Fracchiolla NS; Department of Hematology-Oncology and BMT Unit, IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Giglio F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Forghieri F; Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Vitale A; Hematology, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
  • Chiaretti S; Hematology, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
  • Papayannidis C; Institute of Hematology "L. and A". Seragnoli, University Hospital S. Orsola-Malpighi, Bologna, Italy.
  • Piccini M; Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
  • Mulè A; Department of Hematology I, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
  • Bocchia M; Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy.
  • Leoncin M; Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venezia-Mestre, Venice, Italy.
  • Gurrieri C; Dipartimento Strutturale Aziendale Medicina, University of Padova, Padova, Italy.
  • Aprile L; S.C. Ematologia, Ospedale S.G. Moscati, Taranto, Italy.
  • Lunghi M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
  • Bonifacio M; Department of Medicine, Section of Hematology, Verona University, Verona, Italy.
  • Pasciolla C; Hematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Cerrano M; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Turin, Italy.
  • Fumagalli M; Clinica Ematologica, Ospedale San Gerardo ASST, Monza, Italy.
  • Foà R; Hematology, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
  • Candoni A; Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Integrata Friuli Centrale (ASUFC), Udine, Italy.
Leuk Res ; 122: 106963, 2022 11.
Article en En | MEDLINE | ID: mdl-36155352
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Enfermedad Hepática Inducida por Sustancias y Drogas / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Idioma: En Revista: Leuk Res Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Enfermedad Hepática Inducida por Sustancias y Drogas / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Idioma: En Revista: Leuk Res Año: 2022 Tipo del documento: Article